Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease”.
Clinical Benefit
| Substantial |
Le service médical rendu par FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé est important.
|
Clinical Added Value
| no clinical added value |
FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé n'apporte pas d'amélioration du service médical rendu (ASMR V) par rapport aux autres bronchodilatateurs de longue durée d'action disponibles dans cette indication.
|
eNq1mFFv2jAQx9/5FFHeSQgtLZsC1cbaDanVGC3atBdkkksxC3Z6toHu088hVIPJUVeDH2M7/7v4/v75lPhqs8y9FaCgnPX8KGj5HrCEp5Q99vzJw02z61/1G/GCrMjessugFURt30tyIkTPL2eDGRAmgh93t59Avw/o9xtezGcLSOTBOiVpHnwhYn5HinKNF684Tb0lyDlPe36h5HbUi4VEnUV/zfGXKEgCcbgb2Z9dTM/3x+OwFPsPVSUAbwl7NIoCs9JMFCIwOSASHjk+1+R7ZqVNxRgEV5jAiMj5CPmKppAaQ2QkF2AVJFun94CrHGQZxCgeLpKlsBInC7IZw9PQnPQHPTuQG9lsNaPLbuvy/KITdTtnbatQuLdV5irojwiT6cV5uxu1QmBhxnHJCUXL2ow4SpI7qgoVg0NjOYqD8PRq9VMqipw8BwtR2G4VQaKnAfXxd/ch5Rc8oAZSrvfsH32m8jx8Y9aTHS4cZVzSaMAVkzXUuBnbbsSAMwmb+oragU5udl6kIE4n+5szM+RHapbTxBZpGjoKhJyMh/VEOyUMPhIBE3RHg++UpXwtTk+Z/ao6yr7YgtIoWmAaTdvvuhdRp2N9iH5qC9XcMNcKeQGh5g8Vx2BlyDJ+LFC0K81SL548mR23fQ5PSA41nU7Tki3ahy+NmTOnuztF1YRR9PP1g609vinA5/vto1Gapr2Xwtpx1wXMtRdr8367s6sD7qQFVmgGx1zKQrwPw/V6HcyJaAqidynI8ORg37tL3TXgTi7sqoGp4Ogo9Vl1672tQrYH7bUr/dg2dff+rh02xpCo4IhaVEx2Rs7h9elh/LdHdZb26IAe7sJs+0kiKWeu+hw1MyoehX9dVnaDmg9fs4zW/A+ptWUcVv9i+o04LP/D9Bt/AFaO5Sk=
y1ndu0jvsmmkhQX5
